Lupus Research Institute: Benlysta(TM) Trial Results in an Historic Research Breakthrough and Victory for People ...(ivity and the responses to treatment ex...)
Navigation Links
| HOME >> BIOLOGY >> TECHNOLOGY |
Lupus Research Institute: Benlysta(TM) Trial Results in an Historic Research Breakthrough and Victory for People With Lupus
Date:11/2/2009
ivity, and the responses to treatment," explained Richard Furie, MD, chief of the division of rheumatology and allergy-clinical rheumatology at North Shore-LIJ Health System in New York. "And most important, the two positive trials will allow Human Genome Sciences and GlaxoSmithKline to file for drug approval with regulatory agencies around the world."
"The Benlysta trials are the first well-designed and conducted, comprehensive studies that assessed several measurements of disease," said Daniel J. Wallace, MD, clinical professor of medicine at the David Geffen School of Medicine at UCLA. "These trials are a breakthrough for utilizing a methodology that enables researchers to demonstrate disease improvement, and represent a solid path forward for people with lupus."
"As the organization uniquely dedicated to funding bold approaches to novel research in lupus, the Lupus Research Institute commends HGS and GSK for their commitment and courage in pursuing innovative science, state of the art technology, and smart trial design which has put Benlysta on the road to become the first new drug for lupus that can potentially win FDA approval and start to roll out to physicians and patients," said Dowd.
The LRI funds innovative and creative research to discover new scientific solutions for lupus, and assists in recruiting patients to participate in trials to bring safe and effective treatments to market for people with lupus.
"We thank the hundreds of people with lupus who enrolled and took part in these important trials," Dowd said.
To learn more about lupus clinical trials, visit LupusTrials.org.
SOURCE Lupus Research Institute
'/>"/>
| SOURCE Lupus Research Institute Copyright©2009 PR Newswire. All rights reserved |
Related biology technology :
1. ZymoGenetics and Merck Serono Receive FDA Special Protocol Assessment for Atacicept Pivotal Study in Lupus Nephritis
2. Dynavax Reports Progress in Lupus Program With Inhibitor of TLR7 and TLR9
3. Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE)
4. Human Genome Sciences Reports Positive Long-Term Data for BENLYSTA(TM) (Formerly LymphoStat-B(R)) in Patients With Active Systemic Lupus Erythematosus
5. Human Genome Sciences to Host July 20 Conference Call to Discuss Top-Line Phase 3 Results for Benlysta(TM) (Formerly Lymphostat-B(R)) in Systemic Lupus Erythematosus
6. Biologic Agents Will Drive the Systemic Lupus Erythematosus Drug Market to More Than Quadruple to Nearly $2 Billion in 2018
7. Promise of a New Lupus Treatment Is a Groundbreaking Achievement
8. Research Triangle Area Health Care Collaborative Launches Bridges to Excellence(R) Initiative to Improve Quality and Lower Costs
9. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
10. BioMarin Licenses Technology From Leading Cystic Fibrosis Research Laboratory at the University of California, San Francisco
11. IDM Pharma Names Dr. Jeffrey W. Sherman Chief Medical Officer and Senior Vice President of Research and Development
Post Your Comments:
Breaking Biology Technology:Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 2Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 3Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics 4New antioxidant compounds have been identified in foods such as olive oil, honey and nuts 2Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit 2Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit 3Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit 4PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision 2
[0] Critical Step Toward Commercialization of Pre-Symptomatic Diagnosis of Ovarian Cancer Achieved by Arrayit Diagnostics[0] New antioxidant compounds have been identified in foods such as olive oil, honey and nuts[0] Transgenomic Announces the Commercial Launch of SURVEYOR(R) Scan K-RAS Mutation Detection Kit[0] PharmAthene Announces Updated Time for Conference Call to Review BARDA rPA Decision
Other Biology Technology:Midwest life-science company Perrigo globalizes under the radar 2Midwest life-science company Perrigo globalizes under the radar 3Midwest life-science company Perrigo globalizes under the radar 4Midwest life-science company Perrigo globalizes under the radar 5Test center for RFID capabilities opens next week 2
Breaking Biology News(10 mins):77 percent of European pigs are castrated without anesthetic 2Tropical forests affected by habitat fragmentation store less biomass and carbon dioxide 2Tropical forests affected by habitat fragmentation store less biomass and carbon dioxide 3Carnegie Mellon researchers receive grant 2Small mechanical forces have big impact on embryonic stem cells 10410 1Small mechanical forces have big impact on embryonic stem cells 10410 2A major step in making better stem cells from adult tissue 10407 1A major step in making better stem cells from adult tissue 10407 2A major step in making better stem cells from adult tissue 10407 3A major step in making better stem cells from adult tissue 10407 4Project Runway Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design 59703 1Project Runway Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design 59703 2Project Runway Designer in Philadelphia for AIDS Walk Philly to Educate About Living with HIV through Living Positive By Design 59703 3
Other Biology News:Stroke victims may benefit from stem cell transplants 2Biophysical Society announces new and notable symposium speakers 2Earth's soils bear unmistakable footprints of humans 2
Biology Products:
Rabbit Anti-Coronin / CORO1C Polyclonal Antibody, Unconjugated from IMGENEXRabbit Anti-Histamine H2 Receptor Polyclonal Antibody, Unconjugated from IMGENEXRabbit Anti-Human Retinoic Acid-Induced 3 (RAI3 / RAIG1) Polyclonal Antibody, Unconjugated from IMGENEXMouse Anti-Human GLP Monoclonal Antibody, Unconjugated, Clone 1B7B4 from ProMab Biotechnologies, Inc.
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |